ANTIVIRAL ACTIVITY OF 1-DOCOSANOL, AN INHIBITOR OF LIPID-ENVELOPED VIRUSES INCLUDING HERPES-SIMPLEX

被引:70
作者
KATZ, DH [1 ]
MARCELLETTI, JF [1 ]
KHALIL, MH [1 ]
POPE, LE [1 ]
KATZ, LR [1 ]
机构
[1] MED BIOL INST, DIV IMMUNOL, LA JOLLA, CA 92037 USA
关键词
VIRAL INHIBITION; LONG-CHAIN ALCOHOLS;
D O I
10.1073/pnas.88.23.10825
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This article reports that 1-docosanol, a 22-carbon-long saturated alcohol, exerts a substantial inhibitory effect on replication of certain viruses (e.g., herpes simplex virus and respiratory syncytial virus) within primary target cells in vitro. To study the basis for its viral inhibitory activity, a suspension of 1-docosanol was formulated in an inert and nontoxic surfactant, Pluronic F-68; this suspension exerted potent inhibitory activity on the ability of susceptible viruses to infect cultured target cells. Susceptible viruses included wild-type herpes simplex viruses 1 and 2 as well as acyclovir-resistant herpes simplex virus 2 and also respiratory syncytial virus-all of which are lipid-enveloped. In contrast, nonenveloped poliovirus was not susceptible to the inhibitory action of 1-docosanol. Although the precise mechanism has yet to be defined, current evidence suggests that 1-docosanol inhibits viral replication by interfering with the early intracellular events surrounding viral entry into target cells. It is possible that interaction between the highly lipophilic compound and components of target cell membranes renders such target cells less susceptible to viral fusion and/or entry. If this mechanism proves to be correct, 1-docosanol may provide a broad spectrum activity against many different viruses, especially those with lipid-containing envelopes.
引用
收藏
页码:10825 / 10829
页数:5
相关论文
共 18 条
[1]   SUCCESSFUL TREATMENT WITH FOSCARNET OF AN ACYCLOVIR-RESISTANT MUCOCUTANEOUS INFECTION WITH HERPES-SIMPLEX VIRUS IN A PATIENT WITH ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
CHATIS, PA ;
MILLER, CH ;
SCHRAGER, LE ;
CRUMPACKER, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :297-300
[2]  
Chien Jr. L. T., 1975, SELECTIVE INHIBITORS, P227
[3]  
CLARK LL, 1987, Patent No. 4670471
[4]   ACYCLOVIR-RESISTANT HERPES-SIMPLEX VIRUS-INFECTIONS IN PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
ERLICH, KS ;
MILLS, J ;
CHATIS, P ;
MERTZ, GJ ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GRANT, RM ;
CRUMPACKER, CS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :293-296
[5]  
HIRSCH MS, 1990, VIROLOGY, V2, P441
[6]  
Johnson W., 1988, J AM COLL TOXICOL, V7, P359
[7]   CHEMOTHERAPY - ANTIVIRAL AGENTS COME OF AGE [J].
MAUGH, TH .
SCIENCE, 1976, 192 (4235) :128-132
[8]   EVALUATION OF TRIACONTANOL-CONTAINING COMPOUNDS AS ANTIINFLAMMATORY AGENTS USING GUINEA-PIG MODELS [J].
MCBRIDE, PT ;
CLARK, L ;
KRUEGER, GG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 89 (04) :380-383
[9]   ELECTRON MICROSCOPY OF HERPES SIMPLEX VIRUS .I. ENTRY [J].
MORGAN ;
ROSE, HM ;
MEDNIS, B .
JOURNAL OF VIROLOGY, 1968, 2 (05) :507-+
[10]  
PRUSSOFF WH, 1972, VIRUS CELL INTERACTI, V22, P135